KM Research Hub
← 返回结果库查看论文详情PubMed ↗
READ-ONLY DIGITIZATION RESULT

The MURANO study: final analysis and retreatment/crossover substudy results of VenR for patients with relapsed/refractory CLL.

Blood · 2025-Jun-05 · PMID 40009494

Panel C提取完成待 EXE 对齐验证

Time from PD to next treatment

Figure 3. Kaplan-Meier estimates by MRD status and MRD conversion among VenR-treated patients in the overall intent-to-treat population. (A) Time to MRD∗ conversion; (B) time from conversion to PD; (C) time from PD to next treatment. ∗MRD was categorized as uMRD (<1 CLL cell per 10 000 leukocytes; MRD value <0.0001 [10 –4 ]) and MRD + (≥10 –4 ).

算法:legacy-0.5.0引擎:enhanced-linux
质量评分1.00
质量通过是
预期曲线1
实际曲线1
X 范围-
Y 范围-

曲线数据

网页最多预览 200 行,完整数据请下载 CSV 或 JSON。

当前面板没有可预览的 `curves_mapped.csv` 数据。
历史版本(1)

重跑只新增版本,不覆盖旧结果;正式可用状态仅授予通过 EXE 基准或人工复核的版本。

版本状态验证曲线时间
legacy-0.5.0complete待验证12026-07-23T16:30:11+00:00